Philips Launches Interventional Configuration To Assist In Stroke Assessment

June 4, 2010

Philips Allura Xper interventional X-ray system designed to visualize vessel structure beyond a clot and help physicians identify and assess the size and extent of an ischemic stroke.

Andover, Mass., USA – Today Royal Philips Electronics (NYSE: PHG, AEX: PHI) introduced Philips VasoCT, an intra-vascular interventional configuration for the Philips Allura Xper interventional X-ray system designed to visualize vessel structure beyond a clot and help physicians identify and assess the size and extent of an ischemic stroke. This ensures angiography suite treatment as quickly as possible, thus helping to improve outcomes and quality of life for the patient. VasoCT is based on a 3D rotational scan and a special injection protocol.


Stroke affects 15 million people worldwide each year, with five million people dying from strokes annually . It is the third leading cause of death in the U.S. and the number one reason for adult disability.  Thirty percent of those who have had a stroke need assistance walking, 26 percent become nursing home residents, and 19 percent have trouble speaking.


"Time is most essential when a stroke occurs.” said Bert van Meurs, senior vice president of Interventional X-ray for Philips Healthcare." VasoCT allows physicians a clear view on the location and size of the occlusion and surrounding cerebral blood vessels, which leads to assessment and implementation of treatment. VasoCT also visually aids physicians in navigating through the clot in the right direction.


Receiving quick medical attention significantly lowers the risk of disability and death. Through a rotational scan in the interventional neuro radiology suite, VasoCT reveals key information about cerebral vascular structures in detail.  It is one of the most comprehensive interventional imaging configurations in the Philips interventional X-ray suite, displaying the nuances and complexities beyond the actual occlusion and allowing for navigation in real time.


Professor Jacques Moret, M.D., a leading global authority on neuro interventional techniques said, "A stroke is a life-threatening condition that can get worse quickly unless the right diagnosis and treatment decisions are made in time. VasoCT provides physicians with the information needed to make important decisions at a crucial moment for the stroke patient."


VasoCT will be available in the near future as an interventional configuration to the Philips Allura Xper interventional neuro radiology suite. 


1. World Health Organization, The Atlas of Heart Disease and Stroke
2. Center for Disease Control,“Stroke Facts“

3. American Heart Foundation, Heart Disease and Stroke Statistics—2007 Update

For media inquiries, please contact:

Steve Kelly, Director, Public Relations
Tel: +1 425-487-7479

Ian Race, Senior Manager, Public Relations
Tel: +1 978-659-4624


About Royal Philips Electronics

Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is a diversified Health and Well-being company, focused on improving people’s lives through timely innovations. As a world leader in healthcare, lifestyle and lighting, Philips integrates technologies and design into people-centric solutions, based on fundamental customer insights and the brand promise of “sense and simplicity”. Headquartered in the Netherlands, Philips employs more than 116,000 employees in more than 60 countries worldwide. With sales of $32.3 billion (EUR 23 billion) in 2009, the company is a market leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as lifestyle products for personal well-being and pleasure with strong leadership positions in flat TV, male shaving and grooming, portable entertainment and oral healthcare. News from Philips is located at  

View all News


You are about to visit a Philips global content page

You are about to visit the Philips USA website.

Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.